CYBREX GENTAMICIN— 510(k) K801084

Substantially Equivalent

Abbott Laboratories

FDA 510(k) clearance K801084 for CYBREX GENTAMICIN, Substantially Equivalent on 1980-05-23. Applicant: Abbott Laboratories. Device class: 2.

Clearance details

Applicant: Abbott Laboratories
Product code: Code LCQ
Device class: Class 2
Regulation: 21 CFR 862.3450
Advisory panel: Clinical Toxicology
Date received: 1980-05-07
Decision date: 1980-05-23
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Abbott Park, IL, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code LCQ

K972609 — VARIANT EXPRESS GLYCOHEMOGLOBIN PROGRAM1997-08-06
K955569 — INNOFLUOR GENTAMICIN ASSAY SYSTEM1996-02-09
K945523 — COBAS(R)-FP REAGENTS FOR GENTAMICIN AND COBAS(R)-FP GENTAMICIN CALIBRATORS1995-03-09
K943550 — GENTAMICIN FPIA REAGENT SET AND CALIBRATORS1994-11-17
K905721 — OPUS GENTAMICIN1991-02-21

More clearances from Abbott Laboratories

K252424 — Anti-HCV Next2026-04-28
K243500 — ARCHITECT iGentamicin2025-07-09
K243168 — Alinity i Rubella IgG2025-06-20
K243283 — Alinity h-series System2025-02-20
K233932 — Alinity i Toxo IgM2024-08-30

Data sourced from openFDA. This site is unofficial and independent of the FDA.